-
公开(公告)号：US5605688A
公开(公告)日：1997-02-25
申请号：US302391
申请日：1994-09-08
申请人： Adolf Himmler , Rudolf Hauptmann , Norbert Hauel , Gunther Adolf , Peter Swetly
发明人： Adolf Himmler , Rudolf Hauptmann , Norbert Hauel , Gunther Adolf , Peter Swetly
IPC分类号： A61K38/21 , A61K38/00 , A61P31/12 , A61P35/00 , A61P37/04 , A61P43/00 , C07H21/04 , C07K14/52 , C07K14/555 , C07K14/56 , C07K14/565 , C07K16/00 , C12N1/20 , C12N1/21 , C12N15/09 , C12N15/20 , C12N15/21 , C12P21/02 , C12R1/19
CPC分类号： C07K14/555 , A61K38/00
摘要： This invention relates to a process for preparing recombinant horse and dog interferons and the interferons themselves.
摘要翻译： 本发明涉及一种制备重组马和狗干扰素以及干扰素本身的方法。
-
公开(公告)号：US5798228A
公开(公告)日：1998-08-25
申请号：US805165
申请日：1997-02-24
申请人： Adolf Himmler , Rudolf Hauptmann , Norbert Hauel , Gunther Adolf , Peter Swetly
发明人： Adolf Himmler , Rudolf Hauptmann , Norbert Hauel , Gunther Adolf , Peter Swetly
IPC分类号： A61K38/21 , A61K38/00 , A61P31/12 , A61P35/00 , A61P37/04 , A61P43/00 , C07H21/04 , C07K14/52 , C07K14/555 , C07K14/56 , C07K14/565 , C07K16/00 , C12N1/20 , C12N1/21 , C12N15/09 , C12N15/20 , C12N15/21 , C12P21/02 , C12R1/19
CPC分类号： C07K14/555 , A61K38/00
摘要： This invention relates to a process for preparing recombinant horse and dog interferons and the interferons themselves.
摘要翻译： 本发明涉及一种制备重组马和狗干扰素和干扰素本身的方法。
-
3.发明授权DNA encoding equine-gamma interferon and recombinant production of equine IFN-.gamma. polypeptides 失效编码马γ干扰素的DNA和马IFN-γ多肽的重组产生
公开(公告)号：US5602010A
公开(公告)日：1997-02-11
申请号：US263214
申请日：1994-06-17
申请人： Rudolf Hauptmann , Adolf Himmler , Peter Swetly
发明人： Rudolf Hauptmann , Adolf Himmler , Peter Swetly
IPC分类号： G01N33/53 , A61K38/00 , A61K38/21 , A61P43/00 , C07K14/005 , C07K14/195 , C07K14/52 , C07K14/555 , C07K14/57 , C07K16/00 , C07K16/24 , C12N5/10 , C12N15/02 , C12N15/09 , C12N15/23 , C12P21/02 , C12P21/08 , C12R1/19 , C12R1/865 , C12R1/91 , G01N33/577 , C12N1/21 , C12N15/71
CPC分类号： C07K16/249 , C07K14/57 , A61K38/00
摘要： The present invention relates to a process for preparing horse interferon-gamma (equine interferon gamma, EqIFN-.gamma., DNA sequences which encode this polypeptide, suitable vectors and host organisms containing these DNA sequences and the EqIFN-.gamma. itself. The invention further relates to partial DNA sequences which encode polypeptides which differ structurally from the natural EqIFN-.gamma. polypeptide. The use of the proteins is also described.
摘要翻译： 本发明涉及制备马干扰素-γ（马干扰素γ，EqIFN-γ，编码该多肽的DNA序列，合适的载体和含有这些DNA序列的宿主生物体和EqIFN-γ本身）的方法，本发明还涉及 编码与天然EqIFN-γ多肽结构不同的多肽的部分DNA序列也描述了蛋白质的用途。
-
公开(公告)号：US06440693B1
公开(公告)日：2002-08-27
申请号：US08484307
申请日：1995-06-07
IPC分类号： C12N1509
CPC分类号： G01N33/57484 , A61K38/00 , C07K14/7151 , C12Q1/6886 , C12Q2600/136 , G01N33/6863 , Y02A50/473 , Y10S930/12 , Y10S930/144
摘要： DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 编码TNF结合蛋白的DNA序列和该蛋白质构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 重组TNF结合蛋白用于药物制剂中，用于治疗TNF具有有害作用的适应症。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 受体和/或其对TNF的生物活性的影响。
-
公开(公告)号：US07264944B1
公开(公告)日：2007-09-04
申请号：US09525998
申请日：2000-03-15
CPC分类号： C07K14/7151 , A61K38/00 , C12Q1/6886 , C12Q2600/158 , G01N33/6863 , Y02A50/473
摘要： The present invention provides DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 本发明提供了编码TNF结合蛋白的DNA序列和该蛋白构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 重组TNF结合蛋白用于治疗TNF具有有害作用的适应症的药物制剂中。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 受体和/或其对TNF的生物活性的影响。
-
公开(公告)号：US06294352B1
公开(公告)日：2001-09-25
申请号：US08383676
申请日：1995-02-01
IPC分类号： C12N1500
CPC分类号： G01N33/57484 , A61K38/00 , C07K14/7151 , C12Q1/6886 , C12Q2600/136 , G01N33/6863 , Y02A50/473 , Y10S930/12 , Y10S930/144
摘要： DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequence can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 编码TNF结合蛋白的DNA序列和该蛋白质构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 重组TNF结合蛋白用于治疗TNF具有有害作用的适应症的药物制剂中。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 受体和/或其对TNF的生物活性的影响。
-
公开(公告)号：US06221675B1
公开(公告)日：2001-04-24
申请号：US08477639
申请日：1995-06-07
IPC分类号： G01N33566
CPC分类号： G01N33/6863 , A61K38/00 , C07K14/7151 , C12Q1/6886 , C12Q2600/136 , G01N33/57484
摘要： DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF is receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 编码TNF结合蛋白的DNA序列和该蛋白质构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 是受体和/或其对TNF的生物活性的影响。
-
8.发明授权Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF 失效使用具有结合TNF能力的多肽来改善TNF的有害作用的方法公开(公告)号：US07282483B2
公开(公告)日：2007-10-16
申请号：US09898234
申请日：2001-07-03
IPC分类号： A61K38/16 , C07K14/715
CPC分类号： C07K14/7151 , A61K38/00 , C12Q1/6886 , C12Q2600/158 , G01N33/6863 , Y02A50/473
摘要： The present invention provides DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 本发明提供了编码TNF结合蛋白的DNA序列和该蛋白构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 重组TNF结合蛋白用于治疗TNF具有有害作用的适应症的药物制剂中。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 受体和/或其对TNF的生物活性的影响。
-
9.发明授权Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF 失效使用具有结合TNF能力的多肽来改善TNF的有害作用的方法公开(公告)号：US06417158B1
公开(公告)日：2002-07-09
申请号：US08477638
申请日：1995-06-07
IPC分类号： A61K3819
CPC分类号： G01N33/57484 , A61K38/00 , C07K14/7151 , C12Q1/6886 , C12Q2600/136 , G01N33/6863 , Y02A50/473 , Y10S930/12 , Y10S930/144
摘要： DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 编码TNF结合蛋白的DNA序列和该蛋白质构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 重组TNF结合蛋白用于治疗TNF具有有害作用的适应症的药物制剂中。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 受体和/或其对TNF的生物活性的影响。
-
公开(公告)号：US07238776B2
公开(公告)日：2007-07-03
申请号：US09899422
申请日：2001-07-03
CPC分类号： C07K14/7151 , A61K38/00 , C12Q1/6886 , C12Q2600/158 , G01N33/6863 , Y02A50/473
摘要： The present invention provides DNA sequences coding for a TNF-binding protein and for the TNF receptor of which this protein constitutes the soluble domain. The DNA sequences can be used for preparing recombinant DNA molecules in order to produce TNF-binding protein and TNF receptor. Recombinant TNF-binding protein is used in pharmaceutical preparations for treating indications in which TNF has a harmful effect. With the aid of the TNF receptor or fragments thereof or with the aid of suitable host organisms transformed with recombinant DNA molecules containing the DNA which codes for the TNF receptor or fragments or modifications thereof, it is possible to investigate substances for their interaction with the TNF receptor and/or for their effect on the biological activity of TNF.
摘要翻译： 本发明提供了编码TNF结合蛋白的DNA序列和该蛋白构成可溶性结构域的TNF受体。 DNA序列可用于制备重组DNA分子，以产生TNF结合蛋白和TNF受体。 重组TNF结合蛋白用于治疗TNF具有有害作用的适应症的药物制剂中。 借助于TNF受体或其片段或借助含有编码TNF受体的DNA的重组DNA分子或其片段或修饰物转化的合适的宿主生物，可以研究它们与TNF相互作用的物质 受体和/或其对TNF的生物活性的影响。
-
-
-
-
-
-
-
-
-
搜索结果
35 条记录 (耗时 0.031 秒)
